In this study, we provided evidence that it has a high sensitivity of COVID-19 in all the 11 types of cancers (including lung, breast, colorectum, prostate, stomach, liver, esophagus, cervix, thyroid, ovary, and kidney cancer), and GINS1 played a vital role in this process. This evidence concerns the gene GINS1 and kidney cancer.